Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Shares Outstanding (2020 - 2025)

Trulieve Cannabis (TCNNF) has 6 years of Shares Outstanding data on record, last reported at $169.1 million in Q4 2025.

  • For Q4 2025, Shares Outstanding rose 627.97% year-over-year to $169.1 million; the TTM value through Dec 2025 reached $169.1 million, up 627.97%, while the annual FY2025 figure was $169.1 million, N/A changed from the prior year.
  • Shares Outstanding reached $23.2 million in Q4 2025 per TCNNF's latest filing, down from $191.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $191.1 million in Q3 2025 and bottomed at $23.2 million in Q2 2025.
  • Average Shares Outstanding over 5 years is $127.7 million, with a median of $162.1 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: surged 3507.76% in 2021, then tumbled 87.51% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $51.9 million in 2021, then skyrocketed by 207.72% to $159.8 million in 2022, then increased by 0.16% to $160.0 million in 2023, then tumbled by 85.48% to $23.2 million in 2024, then soared by 627.97% to $169.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $169.1 million in Q4 2025, $167.9 million in Q3 2025, and $167.9 million in Q2 2025.